Resource Library
See how top researchers are using our technology to predict durable responses and unlock pre-clinical meaning.
Rapid Generation of Reporter Cells with mRNA EXPRESS™ for Live Cell-Binding Assays on the Beacon® Optofluidic Platforms
Gain Deeper Insights into Antibody Functionality Using High-Throughput Cell-Based Internalization Assays
Using Nanoscale Bioreactors to Characterize Sub-populations of CHO Clones and Screen Transfected Pools
Accelerating Internalizing Antibody Discovery with Bruker Cellular Analysis Optofluidic Platforms
Revolutionize Antibody Discovery with Opto® B Discovery on the Beacon® Platform
Beacon® Optofluidic Platform
The Beacon Discoveryâ„¢ Optofluidic System
Functional Interrogation Of Human T Cells Using The Accessible Beacon Discovery Optofluidic System
Opto® T Cell Profiling Workflow on the Beacon® Platform
Beacon® Optofluidic System Grant Support Document
Opto® Memory B Discovery Camelid: Discover Heavy Chain Antibodies (HCAbs) with Single B Cell Screening
Opto® Memory B Discovery Camelid: Discover Heavy Chain Antibodies (HCAbs) with Single B Cell Screening
Harnessing the Beacon Optofluidic Platform for Streamlined Discovery of Internalizing Antibodies
Enabling iPSC Cell Line Development Using Bruker’s Optofluidic Systems
Bring Product Quality Assessment into Early Clone Selection with the Opto® Assure Aggregation Assay
Catalent Biologics on Cell Line Development
Increase CDMO Revenue with the Opto Cell Line Development Workflow
Automated Cell Line Development on the Beacon® Platform
FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development
Opto® B Discovery: Relative Affinity Ranking for Soluble Antigens
Going Beyond Simple Antibody Hit Generation in Opto® B Discovery with Relative Affinity Ranking for Soluble Antigens